Last week, the White House announced its plans to alter trade rules it claimed had been flouted by China-founded e-commerce sites. In a fact sheet, the Biden administration revealed that its proposed regulations targeted the de minimis exception, which permitted imported products to enter the United States without taxes or duties if the aggregate fair retail price of the shipment was $800 or less.
The exemption threshold was raised from $200 in 2015 to $800 to help small businesses, including sellers on e-commerce sites such as eBay.
The fact sheet noted that total shipments that claimed this exemption during the last 10 years had increased to more than a billion from only 140 million annually, with most of the shipments coming from these foreign platforms. The Biden Administration explained that the rise in shipments claiming this exemption had made it harder to enforce consumer protection rules and intellectual property rights, health and safety requirements, and trade regulations. It added that it had also undercut U.S. businesses and workers while making it more difficult to prevent illicit goods from entering the country.
In a statement, Secretary of Commerce Gina M. Raimondo claimed that these Chinese platforms had bypassed tariffs, which harmed American businesses and workers that had been denied an equal opportunity to trade. With these new actions, Raimondo noted, the administration was clamping down on efforts by Chinese companies to undercut businesses and workers in the U.S. while also standing up for consumers in the country.
The proposed regulations would exclude roughly 40% of all imports into America from the de minimis exception. This includes 70% of all apparel and textile imports from China. The regulations also asked that Congress approve more comprehensive reform of the aforementioned exemption.
A separate report released by Reuters shows that companies such as Temu and Shein, which ship direct to consumers in the United States from China, have profited greatly from the de minimis exception. Following the administration’s announcement, PDD Holdings’ saw its shares drop 5%. PDD Holdings is the parent company of Chinese e-commerce giants Pinduoduo and Temu.
This news comes after Amazon announced in June that it would be expanding its site offerings to include a section that would compete with Shein and Temu by offering consumers items shipped from China at cheap prices. At the time, it wasn’t clear if the goods sold on the marketplace would be shipped in a way that exempted them from American custom duties, as Shein and Temu both do.
Players in the e-commerce space such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) need to keep tabs on this development and assess what opportunities might open up for them as the federal government makes the proposed changes.
NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL, NXPLW) are available in the company’s newsroom at https://ibn.fm/NXPL
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. The movement toward…
Earlier this month, “Men’s Fitness,” reviewed the unbuzzd clinical trial and described the early study findings as…
Immunotherapy is a relatively new approach in the treatment of cancer and it has had…
PLA gives overlooked biological evidence its own analysis before combining the findings. Published HCC research…
Abdul El-Sayed, a Democrat vying to win a U.S. Senate seat in Michigan, has become…
Many people have been taken by surprise as the flu season gets underway a lot…